VV

Vineet Varma

Active Director Director DIN 11600100
DIN 11600100 First appointment Mar 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vineet Varma

Data last updated:

Vineet Varma is a Director at Eris Lifesciences Limited (since 2026). The company operates in Pharma.

DIN 11600100
Primary Designation Director
Industry Pharma
First Appointment 14 Mar 2026
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eris Lifesciences Limited L24232GJ2007PLC049867
Director14 Mar 20262007Active

Board colleagues of Vineet Varma

Directorship timeline

Open interactive timeline →
Eris Lifesciences Limited
Premium access

Shareholding and investment profile for Vineet Varma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vineet Varma

Vineet Varma currently holds 1 directorship: Eris Lifesciences Limited (Director, since 14 Mar 2026).

Vineet Varma was first appointed on 14 Mar 2026 as Director at Eris Lifesciences Limited.

The current boards of Vineet Varma's companies include Amit Indubhushan Bakshi (Eris Lifesciences Limited), Inderjeet Singh Negi (Eris Lifesciences Limited), Kalpana Vasantrai Unadkat (Eris Lifesciences Limited), Kaushal Kamlesh Shah (Eris Lifesciences Limited), Milind Talegaonkar (Eris Lifesciences Limited), Prashant Gupta (Eris Lifesciences Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available